Nurse Practitioner · Opelika, AL
NPI
1588096200
Since 2013
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2420 Village Professional Drive
Opelika, AL, 36801
Phone (334) 528-7270
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
611 services
Medicare patients, 2024
239
Average age 70
Drug cost, 2024
$4.1M
6,852 prescriptions
Company payments, 2025
$1,548
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carla L Hudson was code 99214 (office e&m - established), 428 times for 213 patients. In total Carla L Hudson billed 611 services in 3 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 428 | 213 | $54.12 | $23K |
| 95251 Test - Miscellaneous | Office | 114 | 69 | $20.55 | $2,343 |
| 99213 Office E&M - Established | Office | 33 | 28 | $34.71 | $1,145 |
| 99214 Office E&M - Established | Facility | 28 | 16 | $17.73 | $496 |
By year: 2022 $26K for 551 services; 2023 $23K for 489 services; 2024 $27K for 611 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carla L Hudson prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 1,141 prescriptions and refills. In total Carla L Hudson wrote 6,852 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 1,141 | 1,288 | 192 | $1.3M |
| Levothyroxine Sodium Generic | 397 | 1,126 | 115 | $7,056 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 337 | 687 | 91 | $60K |
| Ozempic Semaglutide | 336 | 462 | 76 | $431K |
| Farxiga Dapagliflozin Propanediol | 260 | 472 | 61 | $256K |
| Pioglitazone Hcl Generic | 259 | 716 | 72 | $4,426 |
| Jardiance Empagliflozin | 209 | 362 | 40 | $210K |
| Metformin Hcl Generic | 195 | 568 | 59 | $1,858 |
| Tresiba Flextouch U-100 Insulin Degludec | 169 | 307 | 46 | $154K |
| Trulicity Dulaglutide | 143 | 184 | 34 | $176K |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 137 | 294 | 34 | $159K |
| Humalog Kwikpen U-100 Insulin Lispro | 131 | 229 | 40 | $41K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 126 | 233 | 24 | $130K |
| Novolog Flexpen Insulin Aspart | 126 | 271 | 43 | $46K |
| Metformin Hcl Er Metformin Hcl | 124 | 346 | 39 | $1,668 |
Brand drugs: 4,665 claims; generic drugs: 1,595 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carla L Hudson $1,548 ($1,548 in general payments such as food, travel and fees) from 22 companies. The largest payer was Medtronic, Inc. with $212.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 4 | $212 |
| Novo Nordisk Inc NVO | 8 | $165 |
| Radius Health, Inc. | 5 | $144 |
| Insulet Corporation PODD | 6 | $142 |
| Lilly USA, LLC LLY | 6 | $98.3 |
| Sanofi-Aventis U.S. LLC SNY | 5 | $96.36 |
| Tolmar, Inc. | 5 | $75.32 |
| Sequel Med Tech, LLC | 4 | $68.66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $62.4 |
| Corcept Therapeutics CORT | 3 | $61.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.